NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats
Sign Up to like & getrecommendations! Published in 2022 at "eLife"
DOI: 10.7554/elife.72468
Abstract: NBI-921352 (formerly XEN901) is a novel sodium channel inhibitor designed to specifically target NaV1.6 channels. Such a molecule provides a precision-medicine approach to target SCN8A-related epilepsy syndromes (SCN8A-RES), where gain-of-function (GoF) mutations lead to excess… read more here.
Keywords: sodium channel; channel inhibitor; mice; inhibitor ... See more keywords